文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
C. Monzo-Fuentes
发表
Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial
R. Greil, H. Hackl, F. Huemer, 2020, Journal of clinical medicine.